These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 31952977)

  • 41. Plasma proteoglycan prolargin in diagnosis and differentiation of pulmonary arterial hypertension.
    Arvidsson M; Ahmed A; Bouzina H; Rådegran G
    ESC Heart Fail; 2021 Apr; 8(2):1230-1243. PubMed ID: 33403810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Echocardiographic Assessment of Right Ventricular Function and Response to Therapy in Pulmonary Arterial Hypertension.
    Shelburne NJ; Parikh KS; Chiswell K; Shaw LK; Sivak J; Arges K; Tomfohr J; Velazquez EJ; Kisslo J; Samad Z; Rajagopal S
    Am J Cardiol; 2019 Oct; 124(8):1298-1304. PubMed ID: 31481176
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pulsatile haemodynamic parameters are predictors of survival in paediatric pulmonary arterial hypertension.
    Douwes JM; Roofthooft MT; Bartelds B; Talsma MD; Hillege HL; Berger RM
    Int J Cardiol; 2013 Sep; 168(2):1370-7. PubMed ID: 23340486
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Galectin-3 levels are associated with right ventricular functional and morphologic changes in pulmonary arterial hypertension.
    Fenster BE; Lasalvia L; Schroeder JD; Smyser J; Silveira LJ; Buckner JK; Brown KK
    Heart Vessels; 2016 Jun; 31(6):939-46. PubMed ID: 25976729
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Plasma aldosterone levels are elevated in patients with pulmonary arterial hypertension in the absence of left ventricular heart failure: a pilot study.
    Maron BA; Opotowsky AR; Landzberg MJ; Loscalzo J; Waxman AB; Leopold JA
    Eur J Heart Fail; 2013 Mar; 15(3):277-83. PubMed ID: 23111998
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Baseline and Serial Brain Natriuretic Peptide Level Predicts 5-Year Overall Survival in Patients With Pulmonary Arterial Hypertension: Data From the REVEAL Registry.
    Frantz RP; Farber HW; Badesch DB; Elliott CG; Frost AE; McGoon MD; Zhao C; Mink DR; Selej M; Benza RL
    Chest; 2018 Jul; 154(1):126-135. PubMed ID: 29355551
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical Determinants and Prognostic Implications of Right Ventricular Dysfunction in Pulmonary Hypertension Caused by Chronic Lung Disease.
    Prins KW; Rose L; Archer SL; Pritzker M; Weir EK; Olson MD; Thenappan T
    J Am Heart Assoc; 2019 Jan; 8(2):e011464. PubMed ID: 30646788
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Impact of Major Pulmonary Resections on Right Ventricular Function: Early Postoperative Changes.
    Elrakhawy HM; Alassal MA; Shaalan AM; Awad AA; Sayed S; Saffan MM
    Heart Surg Forum; 2018 Jan; 21(1):E009-E017. PubMed ID: 29485957
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Galectin-3 and aldosterone as potential tandem biomarkers in pulmonary arterial hypertension.
    Calvier L; Legchenko E; Grimm L; Sallmon H; Hatch A; Plouffe BD; Schroeder C; Bauersachs J; Murthy SK; Hansmann G
    Heart; 2016 Mar; 102(5):390-6. PubMed ID: 26869635
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical phenotypes and outcomes of pulmonary hypertension due to left heart disease: Role of the pre-capillary component.
    Caravita S; Faini A; Carolino D'Araujo S; Dewachter C; Chomette L; Bondue A; Naeije R; Parati G; Vachiéry JL
    PLoS One; 2018; 13(6):e0199164. PubMed ID: 29920539
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Definitions and diagnosis of pulmonary hypertension.
    Hoeper MM; Bogaard HJ; Condliffe R; Frantz R; Khanna D; Kurzyna M; Langleben D; Manes A; Satoh T; Torres F; Wilkins MR; Badesch DB
    J Am Coll Cardiol; 2013 Dec; 62(25 Suppl):D42-50. PubMed ID: 24355641
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Assessment of Right Ventricular Afterload in COPD.
    Hilde JM; Skjørten I; Hansteen V; Melsom MN; Atar D; Hisdal J; Humerfelt S; Steine K
    COPD; 2016; 13(2):176-85. PubMed ID: 26914261
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gasometric gradients between blood obtained from the pulmonary artery wedge and pulmonary artery positions in pulmonary arterial hypertension.
    Khirfan G; Ahmed MK; Faulx MD; Dakkak W; Dweik RA; Tonelli AR
    Respir Res; 2019 Jan; 20(1):6. PubMed ID: 30621691
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Ventricular Diastolic Pressure Ratio as a Marker of Treatment Response in Pulmonary Hypertension.
    Jose A; King CS; Shlobin OA; Kiernan JM; Cossa NA; Brown AW; Nathan SD
    Chest; 2017 Nov; 152(5):980-989. PubMed ID: 28527879
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A pragmatic approach to risk assessment in pulmonary arterial hypertension using the 2015 European Society of Cardiology/European Respiratory Society guidelines.
    Dardi F; Manes A; Guarino D; Zuffa E; De Lorenzis A; Magnani I; Rotunno M; Ballerini A; Lo Russo GV; Nardi E; Galiè N; Palazzini M
    Open Heart; 2021 Oct; 8(2):. PubMed ID: 34667092
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Age-related differences in hemodynamics and functional status in pulmonary arterial hypertension: Baseline results from the Pulmonary Hypertension Association Registry.
    DesJardin JT; Kolaitis NA; Kime N; Kronmal RA; Benza RL; Elwing JM; Lammi MR; McConnell JW; Presberg KW; Sager JS; Shlobin OA; De Marco T;
    J Heart Lung Transplant; 2020 Sep; 39(9):945-953. PubMed ID: 32507341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relationship between kidney function, hemodynamic variables and circulating big endothelin levels in patients with severe refractory heart failure.
    Kos T; Pacher R; Wimmer A; Bojic A; Hülsmann M; Frey B; Mayer G; Yilmaz N; Skvarilova L; Spinar J; Vitovec J; Toman J; Woloszcuk W; Stanek B
    Wien Klin Wochenschr; 1998 Feb; 110(3):89-95. PubMed ID: 9553203
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Echocardiography in pediatric pulmonary arterial hypertension: early study on assessing disease severity and predicting outcome.
    Ploegstra MJ; Roofthooft MT; Douwes JM; Bartelds B; Elzenga NJ; van de Weerd D; Hillege HL; Berger RM
    Circ Cardiovasc Imaging; 2015 Jan; 8(1):. PubMed ID: 25552488
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.
    Hirsch K; Nolley S; Ralph DD; Zheng Y; Altemeier WA; Rhodes CJ; Morrell NW; Wilkins MR; Leary PJ; Rayner SG
    J Heart Lung Transplant; 2023 Feb; 42(2):173-182. PubMed ID: 36470771
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.